Home > News Center
 
Contact Us
Shanghai BravoBio Co., Ltd.
Add:Suite 14E, Building #5, Haifu Garden, 1365 Dongfang Road, Lujiazui Financial and Trade Zone, Shanghai 200127, China
Tel: +86 21 2025 5516
Fax: +86 21 2025 5517
Email: bd@bravobio.com
News Center
 
EMA safety review favors Merck and GSK HPV vaccines
Nov. 11, 2015
 
EMA recently announced that no proof would link Merck Gardasil/Gardasil 9 and GSK Cervarix to complex regional pain syndrome (CRPS) or postural orthostatic tachycardia syndrome (POTS), after initiating a safety review of the above said vaccines in July. So far, 80 million people have received the jabs.
 
Sanofi and Shantha to supply IPV to India government through UNICEF
Dec. 2, 2015
 
Sanofi and its Indian affiliate, Shantha Biotechnics, will supply injectable inactivated polio vaccines to India's universal immunization program via UNICEF. Sanofi Pasteur's Imovax Polio vaccine has already been supplied the government and it will be soon followed by Shanth's ShanIPV.
 
Novavax takes RSV vaccine into Phase III ahead of schedule
Dec. 8, 2015
 
Novavax recently started a second Phase III trial in pregnant women ahead of schedule to test the vaccine's efficacy in infants through maternal immunization.The trial, which is designed as randomized, observer-blinded and placebo-controlled, will recruit 5,000 to 8,255 pregnant women and last two to four years.
 
Sinovac's HFMD vaccine got CFDA approval
Jan. 6, 2016
 
In Jan 2016, CFDA approved Sinovac's HFMD vaccine against Enterovirus 71 virus, one month after the agency's approval for the same type of vaccine made by the Institute of Medical Biology at the Chinese Academy of Medical Sciences. Now China has two locally made vaccines against HFMD.
Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Next